#news #biotech Bristol Myers pays $650M for rights to Eisai’s phase 1 ADC

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Bristol Myers pays $650M for rights to Eisai’s phase 1 ADC .Bristol Myers pays $650M for rights to Eisai’s phase 1 ADC
ntaylor
Fri, 06/18/2021 – 04:21

from FierceBiotech: Biotech https://ift.tt/3gE01Zb